Erratum to: PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment

被引:0
作者
Dimitrios Mathios
Jacob Ruzevick
Christopher M. Jackson
Haiying Xu
Sagar R. Shah
Janis M. Taube
Peter C. Burger
Edward F. McCarthy
Alfredo Quinones-Hinojosa
Drew M. Pardoll
Michael Lim
机构
[1] The Johns Hopkins University School of Medicine,Department of Neurosurgery
[2] The Johns Hopkins University School of Medicine,Department of Dermatology
[3] The Johns Hopkins University School of Medicine,Department of Biomedical Engineering
[4] The Johns Hopkins University School of Medicine,Department of Pathology
[5] The Johns Hopkins University School of Medicine,Department of Oncology
[6] The Johns Hopkins University School of Medicine,Department of Medicine
[7] Johns Hopkins Hospital,Department of Neurosurgery
来源
Journal of Neuro-Oncology | 2016年 / 128卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:183 / 183
相关论文
共 50 条
[21]   Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues [J].
Ishida, M ;
Iwai, Y ;
Tanaka, Y ;
Okazaki, T ;
Freeman, GJ ;
Minato, N ;
Honjo, T .
IMMUNOLOGY LETTERS, 2002, 84 (01) :57-62
[22]   Expression of Immunomodulatory Molecules PD-1, PD-L1, and PD-L2, and their Relationship With Clinicopathologic Characteristics in Endometrial Cancer [J].
Sungu, Nuran ;
Yildirim, Melahat ;
Desdicioglu, Raziye ;
Aydogdu, Ozge Basaran ;
Kilicarslan, Aydan ;
Dogan, Hayriye Tatli ;
Yazgan, Aylin Kilic ;
Akyol, Mesut ;
Erdogan, Fazli .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2019, 38 (05) :404-413
[23]   Expression of PD-1, PD-L1 and PD-L2 is associated with differentiation status and histological type of endometrial cancer [J].
Mo, Zhongfu ;
Liu, Jing ;
Zhang, Qiuyang ;
Chen, Zhiquan ;
Mei, Jiandong ;
Liu, Lunxu ;
Yang, Shijie ;
Li, Huina ;
Zhou, Lifei ;
You, Zongbing .
ONCOLOGY LETTERS, 2016, 12 (02) :944-950
[24]   Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation [J].
Kinch, Amelie ;
Sundstrom, Christer ;
Baecklund, Eva ;
Backlin, Carin ;
Molin, Daniel ;
Enblad, Gunilla .
LEUKEMIA & LYMPHOMA, 2019, 60 (02) :376-384
[25]   Association of PD-1, PD-L1 and PD-L2 expression with clinicopathological factors in tongue squamous cell carcinoma [J].
Tsuchihashi, Kei ;
Nakatsugawa, Munehide ;
Asanuma, Hiroko ;
Miyazaki, Akihiro ;
Torigoe, Toshihiko .
CANCER SCIENCE, 2018, 109 :498-498
[26]   Serum Level of PD-1, PD-L1, and PD-L2 as a New Biomarker for Esophageal Cancer [J].
Akutsu, Yasunori ;
Murakami, Kentaro ;
Hanari, Naoyuki ;
Kano, Masayuki ;
Uesato, Masaya ;
Ota, Takumi ;
Suito, Hiroshi ;
Matsumoto, Yasunori ;
Takahashi, Masahiko ;
Matsubara, Hisahiro .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 :S694-S694
[27]   Downregulation of Immunosuppressive Molecules, PD-1 and PD-L1 but not PD-L2, in the Patients with Multiple Sclerosis [J].
Javan, Mohammad Reza ;
Aslani, Saeed ;
Zamani, Mohammad Reza ;
Rostamnejad, Javad ;
Asadi, Milad ;
Farhoodi, Mahdi ;
Nicknam, Mohammad Hossein .
IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2016, 15 (04) :296-302
[28]   PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer [J].
Monneur, Audrey ;
Goncalves, Anthony ;
Bertucci, Francois .
BULLETIN DU CANCER, 2018, 105 (03) :261-272
[29]   Integrative assessment of clinicopathological parameters and the expression of PD-L1, PD-L2 and PD-1 in tumor cells of retroperitoneal sarcoma [J].
Miyake, Makito ;
Oda, Yuki ;
Nishimura, Nobutaka ;
Morizawa, Yosuke ;
Ohnishi, Sayuri ;
Hatakeyama, Kinta ;
Fujii, Tomomi ;
Hori, Shunta ;
Gotoh, Daisuke ;
Nakai, Yasushi ;
Anai, Satoshi ;
Torimoto, Kazumasa ;
Tsukamoto, Shinji ;
Fujii, Hiromasa ;
Kido, Akira ;
Honoki, Kanya ;
Matsumura, Yoshiaki ;
Okajima, Eijiro ;
Tanaka, Nobumichi ;
Fujimoto, Kiyohide .
ONCOLOGY LETTERS, 2020, 20 (05)
[30]   The PD-1 pathway in systemic lupus erythematosus: The Ligands of PD-1, PD-L1 and PD-L2, are also susceptibility factors. [J].
Abelson, AK ;
Johansson, C ;
Kozyrev, S .
ARTHRITIS AND RHEUMATISM, 2004, 50 (09) :S203-S203